News Item

  • September 23, 2019

WATERTOWN, Mass. – C4 Therapeutics (C4T) today announced the appointment of Ryan B. Corcoran, M.D., Ph.D., to the Company’s Scientific Advisory Board...

News Item

  • March 13, 2019

WATERTOWN, Mass. – March 13, 2019 – C4 Therapeutics (C4T) today announced the appointment of Adam Crystal M.D., Ph.D. as...

News Item

  • January 4, 2019

C4 Therapeutics Announces Transformation of Strategic Collaboration to Discover and Develop Degrader-based Medicines with Roche WATERTOWN, Mass. – C4 Therapeutics...

News Item

  • January 4, 2019

Biogen and C4 Therapeutics Enter into Strategic Collaboration to Discover and Develop Potential New Treatments for Neurological Conditions C4T’s targeted...

News Item

  • May 3, 2018

WATERTOWN, Mass. – C4 Therapeutics (C4T) today announced that Stewart Fisher, Ph.D. has been promoted to Chief Scientific Officer. Since...

News Item

  • May 3, 2018

WATERTOWN, Mass. – C4 Therapeutics (C4T) today announced that Andrew Phillips, Ph.D. has been appointed as President and Chief Executive...

News Item

  • March 26, 2018

CAMBRIDGE, Mass. – C4 Therapeutics (C4T) today announced that an independent study featuring targeted protein degradation technologies licensed by the...

News Item

  • November 17, 2017

CAMBRIDGE, Mass. – C4 Therapeutics (C4T) has been named one of the Top Places to Work in Massachusetts in the 10th annual employee-based...

News Item

  • November 14, 2017

CAMBRIDGE, Mass. – C4 Therapeutics (C4T) today announced it has appointed Ron Kaiser as Chief Financial Officer. Ron has more than...

News Item

  • August 11, 2017

CAMBRIDGE, Mass.– C4 Therapeutics (C4T) today announced the appointment of Michael Kim, Ph.D., as Vice President of Business Development. Dr. Kim comes...